1
|
Fourie S, Aveyard H, Jackson D. Older adolescents participating in sensitive research: The voices we cannot hear. J Clin Nurs 2019; 29:4418-4420. [PMID: 31793112 DOI: 10.1111/jocn.15102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Simona Fourie
- Midwifery and Palliative Care Faculty, Florence Nightingale Nursing, King's College London, London, UK.,Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Helen Aveyard
- Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK
| | - Debra Jackson
- Midwifery and Palliative Care Faculty, Florence Nightingale Nursing, King's College London, London, UK.,Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia.,Oxford Health NHS Foundation Trust, Oxford, UK
| |
Collapse
|
2
|
Impact of a primary care national policy on HIV screening in France: a longitudinal analysis between 2006 and 2013. Br J Gen Pract 2016; 66:e920-e929. [PMID: 27672140 DOI: 10.3399/bjgp16x687529] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2016] [Accepted: 05/09/2016] [Indexed: 10/31/2022] Open
Abstract
BACKGROUND Early diagnosis of HIV infection is a major public health issue worldwide. In 2009, the French National Authority for Health (Haute Autorité de Santé) developed specific guidelines and recommended mass screening of 15-70-year-olds across the general population. The guidelines were supported by communication directed at healthcare professionals, especially GPs. AIM To assess the impact of the national mass screening policy on HIV testing. DESIGN AND SETTING The study used data from the French National Health Insurance Fund database, from January 2006 to December 2013. Males and females aged 15-70 years, excluding HIV-positive individuals and pregnant females, were followed up throughout the 2006-2013 period. During the study period, 2 176 657 person-years and a total of 329 748 different individuals were followed up. METHOD Standardised and non-standardised rates of HIV screening were calculated for each year; the impact of the policy was assessed using adjusted segmented regression analyses. RESULTS Overall, annual HIV screening rates increased over the study period, from 4.2% (95% confidence interval [CI] = 4.2 to 4.3) in 2006 to 5.8% (95% CI = 5.7 to 5.9) in 2013 with a more pronounced trend after 2010 (P<0.0001). This increase was more significant for those who regularly consulted a GP. For these individuals, the policy led to a 20.4% increase (95% CI = 17.0 to 23.8) in HIV screening in 2013 compared with only a 4.5% increase (95% CI = 4.4 to 4.5) for those who did not consult a GP regularly in 2013. CONCLUSION The results show that the mass screening policy coordinated by GPs had a significant impact on HIV testing in France, which could result in positive impacts on public and individual health outcomes.
Collapse
|
3
|
Kok S, Rutherford AR, Gustafson R, Barrios R, Montaner JSG, Vasarhelyi K. Optimizing an HIV testing program using a system dynamics model of the continuum of care. Health Care Manag Sci 2015; 18:334-62. [PMID: 25595433 PMCID: PMC4543429 DOI: 10.1007/s10729-014-9312-0] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2013] [Accepted: 11/26/2014] [Indexed: 12/01/2022]
Abstract
Realizing the full individual and population-wide benefits of antiretroviral therapy for human immunodeficiency virus (HIV) infection requires an efficient mechanism of HIV-related health service delivery. We developed a system dynamics model of the continuum of HIV care in Vancouver, Canada, which reflects key activities and decisions in the delivery of antiretroviral therapy, including HIV testing, linkage to care, and long-term retention in care and treatment. To measure the influence of operational interventions on population health outcomes, we incorporated an HIV transmission component into the model. We determined optimal resource allocations among targeted and routine testing programs to minimize new HIV infections over five years in Vancouver. Simulation scenarios assumed various constraints informed by the local health policy. The project was conducted in close collaboration with the local health care providers, Vancouver Coastal Health Authority and Providence Health Care.
Collapse
Affiliation(s)
- Sarah Kok
- />The IRMACS Centre, Simon Fraser University, Burnaby, British Columbia Canada
| | - Alexander R. Rutherford
- />The IRMACS Centre and Department of Mathematics, Simon Fraser University, Burnaby, British Columbia Canada
| | - Reka Gustafson
- />Vancouver Coastal Health, Vancouver, British Columbia Canada
| | - Rolando Barrios
- />British Columbia Centre for Excellence in HIV/AIDS and Vancouver Coastal Health, Vancouver, British Columbia Canada
| | - Julio S. G. Montaner
- />British Columbia Centre for Excellence in HIV/AIDS and Faculty of Medicine, University of British Columbia, Vancouver, British Columbia Canada
| | - Krisztina Vasarhelyi
- />Faculty of Health Sciences and The IRMACS Centre, Simon Fraser University, Burnaby, British Columbia Canada
| | - on behalf of the Vancouver HIV Testing Program Modelling Group
- />The IRMACS Centre, Simon Fraser University, Burnaby, British Columbia Canada
- />The IRMACS Centre and Department of Mathematics, Simon Fraser University, Burnaby, British Columbia Canada
- />Vancouver Coastal Health, Vancouver, British Columbia Canada
- />British Columbia Centre for Excellence in HIV/AIDS and Vancouver Coastal Health, Vancouver, British Columbia Canada
- />British Columbia Centre for Excellence in HIV/AIDS and Faculty of Medicine, University of British Columbia, Vancouver, British Columbia Canada
- />Faculty of Health Sciences and The IRMACS Centre, Simon Fraser University, Burnaby, British Columbia Canada
| |
Collapse
|
4
|
Poirier C, Aymeric S, Grammatico-Guillon L, Lebeau JP, Bernard L, Le Bret P, Le Moal G, Gras G. Rapid HIV test in family practice. Med Mal Infect 2015; 45:207-14. [PMID: 25982343 DOI: 10.1016/j.medmal.2015.03.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2015] [Revised: 01/19/2015] [Accepted: 03/24/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND The 2010-2014 HIV/AIDS French program recommends using HIV rapid diagnostic tests in family practice. Our aim was to assess the acceptability and feasibility of the RDT in family practice in France. METHODS The first part of this study was to determine the opinions of family practitioners (FPs) concerning the news guidelines for screening and the possible use of rapid HIV tests in their practice. The second part was a feasibility study of the actual use of rapid HIV tests given to FPs during six months. The third part was a qualitative analysis of experience feedback to determine the impediments to using rapid HIV tests. RESULTS Seventy-seven percent of the 352 FPs interviewed were favorable to rapid HIV tests use. The three main impediments were: misinterpretation of test result, complexity of quality control, and lack of training: 23 of the 112 FPs having volunteered to evaluate the rapid HIV tests followed the required training session. Sixty-nine tests were handed out, and three rapid HIV tests were used; the qualitative study involved 12 FPs. The participants all agreed on the difficult use of rapid HIV tests in daily practice. The main reasons were: too few opportunities or requests for use, complex handling, difficulties in proposing the test, fear of having to announce seropositivity, significantly longer consultation. CONCLUSION Although FPs are generally favorable to rapid HIV tests use in daily practice, the feasibility and contribution of rapid HIV tests are limited in family practice.
Collapse
Affiliation(s)
- C Poirier
- Service de médecine interne et maladies infectieuses, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France.
| | - S Aymeric
- Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Service d'information médicale d'épidémiologie et d'économie de la santé, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Équipe émergente éducation éthique santé, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France.
| | - L Grammatico-Guillon
- Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Service d'information médicale d'épidémiologie et d'économie de la santé, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Équipe émergente éducation éthique santé, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France
| | - J P Lebeau
- Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Équipe émergente éducation éthique santé, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Département universitaire de médecine générale, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France
| | - L Bernard
- Service de médecine interne et maladies infectieuses, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France
| | - P Le Bret
- Réseau ville hôpital VIH 37, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France
| | - G Le Moal
- COREVIH centre Poitou-Charentes, service de maladies infectieuses et tropicales, CHRU de Poitiers, 2, rue de la Milétrie, 86021 Poitiers cedex, France
| | - G Gras
- Service de médecine interne et maladies infectieuses, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France
| |
Collapse
|
5
|
Syed IA, Syed Sulaiman SA, Hassali MA, Thiruchelvum K, Lee CK. A qualitative insight of HIV/AIDS patients' perspective on disease and disclosure. Health Expect 2014; 18:2841-52. [DOI: 10.1111/hex.12268] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/20/2014] [Indexed: 11/29/2022] Open
Affiliation(s)
- Imran Ahmed Syed
- School of Pharmaceutical Sciences; Universiti Sains Malaysia (USM); Penang Malaysia
- School of Pharmacy; International Medical University; Kuala Lumpur Malaysia
| | | | | | | | | |
Collapse
|